Altered pharmacokinetics and liver targetability of methotrexate by conjugation with lactosylated albumins.

@article{Han2001AlteredPA,
  title={Altered pharmacokinetics and liver targetability of methotrexate by conjugation with lactosylated albumins.},
  author={J H Han and S. J. Lim and M K Lee and C K Kim},
  journal={Drug delivery},
  year={2001},
  volume={8 3},
  pages={
          125-34
        }
}
To enhance the liver targetability, methotrexate (MTX) was conjugated with albumin previously substituted with varying content of lactose (L0, L5, and L24). The uptake of MTX by rat hepatocytes in vitro increased according to the increase in the lactose content on the albumin conjugates. The MTX level in the plasma and various organs was determined by counting the radioactivity of [3H]MTX and by HPLC assay, separately, to monitor the in vivo fate of MTX not only as total, regardless of forms of… Expand
Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate.
TLDR
Light-controlled release of methotrexate from a dendrimer-based conjugate is reported and evidence suggesting that MTX still attached to the nanoconjugate system is fully able to inhibit the activity of its enzyme target and the growth of cancer cells is provided. Expand
Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin.
TLDR
It was suggested that liposomes containing such novel galactosylated lipid, CHS-ED-LA, had a great potential as drug delivery carriers for hepatocyte-selective targeting. Expand
A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis
TLDR
This review deals with the challenges of conventional systems and achievements of each pharmaceutical class of novel drug delivery vehicle and provides prolonged plasma profile, enhanced and specific activity in vitro and in vivo in animal models. Expand
Novel galactosylated SLN for hepatocyte-selective targeting of floxuridinyl diacetate
This paper describes the preparation and liver-targeting traits of new solid lipid nanoparticles (SLN) containing floxuridinyl diacetate (FUDRA) modified with β-d-galactosides (Gn). FUDRA and Gn wereExpand
Viramidine-Loaded Galactosylated Nanoparticles Induce Hepatic Cancer Cell Apoptosis and Inhibit Angiogenesis
TLDR
Viramidine-encapsulated Gal-SLN has anticancer and anti-angiogenic activities against hepatocarcinoma, and application on breast cancer MCF-7 cells confirmed its specificity against liver cancer HepG2 cells. Expand
Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability
TLDR
The incorporation of N-HLBA into SLNs significantly enhanced the Liver targetability of Cuc B-loaded SLNs and GalSLN had a great potential as a drug delivery carrier for improved liver targetability. Expand
Synthesis of lactosylated piperazinyl porphyrins and their hepatocyte-selective targeting
The aim of this work was the synthesis of a new family of lactosylated piperazinly porphyrins in which the galactoside piperazine moieties are linked to the tetra- and monophenyl ring by an amideExpand
Application of Mono‐ and Disaccharides in Drug Targeting and Efficacy
TLDR
This review focuses on the influence of the structural variations of mono‐ and disaccharides, including changes in sugar type, substituent groups and their positions, as well as length of linker portion, on the targeting of drugs or their efficacy. Expand
Synthesis and characterization of a novel glycoconjugated macromolecule
Abstract In this study, synthesis and characterization of a new galactosylated chitosan with high affinity to HepG2 (a liver cancer cell line) were reported. We designed the novel glycoconjugatedExpand
Synthesis of Lactosylated Piperazinyl Porphyrins and Their Biological Activity
The aim of this work is to synthesize of a new family of lactosylated piperazinly porphyrins, in which the galactoside piperazine moieties are linked to the tetra- and mono-phenyl rings ofExpand
...
1
2
3
...

References

SHOWING 1-10 OF 17 REFERENCES
Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier.
TLDR
It is reported that the galactosylation of the carrier protein BSA significantly enhanced the hepatocyte uptake and liver targetability of MTX and has a great potential as an hepatocyte-directed and more effective liver targeting carrier of drugs for liver diseases. Expand
Pharmacokinetics and Organ-Distribution of 3H-Methotrexate and 3H-Methotrexate-Human Serum Albumin Conjugates in Mice
AbstractThis investigation has been made to elucidate the pharmacokinetics and organ distribution of 3H-methotrexate (MTX) and 3H-MTX-human serum albumin (HSA) conjugate in mice and evaluate theExpand
Pharmacokinetics of methotrexate–albumin conjugates in tumor-bearing rats
TLDR
The potential therapeutic benefit of the MTX(1)-RSA conjugate lies in its very long tumor exposure time and its improved tumor accumulation rate compared to conventional MTX. Expand
Control of in vivo fate of albumin derivatives utilizing combined chemical modification.
TLDR
The results suggest that it is possible to control the hepatic uptake of protein drugs by a combination of introduction of charge or sugar moieties and PEG conjugation. Expand
Effect of chronic bile duct obstruction and LPS upon targeting of naproxen to the liver using naproxen-albumin conjugate.
TLDR
It is concluded that targeting albumin-linked naproxen to non-parenchymal cells in the liver is still feasible under the pathological conditions induced in the present study. Expand
Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variables.
TLDR
This common conjugating procedure produces by-product crosslinking and produces a mix of covalent MTX binding to carboxyl and amino groups of the gelatin, which is consistent with hydrolysis of a peptide bond. Expand
Specific targeting of a lipophilic prodrug of iododeoxyuridine to parenchymal liver cells using lactosylated reconstituted high density lipoprotein particles.
TLDR
Subcellular fractionation of the liver indicated that lactosylated [3H]IDU-Ol2-loaded NeoHDL does not merely associate to cells, but is internalized and delivered to the lysosomes, which shows that IDU can be specifically targeted to the parenchymal liver cell. Expand
Clinical Pharmacokinetics of Methotrexate
SummaryThe absorption of methotrexate following intramuscular injection and oral administration of small doses (>30mg/m2) is rapid and complete, whereas with oral doses in excess of 80mg/m2Expand
Reduced immunogenicity of beta-lactoglobulin by conjugation with carboxymethyl dextran.
TLDR
It is concluded that masking of epitopes by CMD is responsible for the decreased immunogenicity of the beta-LG in these conjugates. Expand
Enhanced lymph node delivery and immunogenicity of hepatitis B surface antigen entrapped in galactosylated liposomes
TLDR
It is concluded that the galactosylated liposomes can target HBsAg to the regional lymph nodes, rich in the antigen-presenting cells and enhance the immunogenicity ofHBsAg more efficiently than do the conventional aluminum phosphate or the ungalactosymic liposome formulations. Expand
...
1
2
...